The spread of β-lactamases that hydrolyze penicillins, cephalosporins and carbapenems among Gram-negative bacteria has limited options for treating bacterial infections. Initially, Klebsiella pneumoniae carbapenemase-2 (KPC-2) emerged as a widespread carbapenem hydrolyzing β-lactamase that also hydrolyzes penicillins and cephalosporins but not cephamycins and ceftazidime. In recent years, single and double amino acid substitution variants of KPC-2 have emerged among clinical isolates that show increased resistance to ceftazidime. Because it confers multi-drug resistance, KPC β-lactamase is a threat to public health. In this study, the evolution of KPC-2 function was determined in nine clinically isolated variants by examining the effects of the substitutions on enzyme kinetic parameters, protein stability and antibiotic resistance profile. The results indicate that the amino acid substitutions associated with KPC-2 natural variants lead to increased catalytic efficiency for ceftazidime hydrolysis and a consequent increase in ceftazidime resistance. Single substitutions lead to modest increases in catalytic activity while the double mutants exhibit significantly increased ceftazidime hydrolysis and resistance levels. The P104R, V240G and H274Y substitutions in single and double mutant combinations lead to the largest increases in ceftazidime hydrolysis and resistance. Molecular modeling suggests that the P104R and H274Y mutations could facilitate ceftazidime hydrolysis through increased hydrogen bonding interactions with the substrate while the V240G substitution may enhance backbone flexibility so that larger substrates might be accommodated in the active site. Additionally, we observed a strong correlation between gain of catalytic function for ceftazidime hydrolysis and loss of enzyme stability, which is in agreement with the 'stability-function tradeoff' phenomenon. The high Tm of KPC-2 (66.5°C) provides an evolutionary advantage as compared to other class A enzymes such as TEM (51.5°C) and CTX-M (51°C) in that it can acquire multiple destabilizing substitutions without losing the ability to fold into a functional enzyme.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452179PMC
http://dx.doi.org/10.1371/journal.ppat.1004949DOI Listing

Publication Analysis

Top Keywords

ceftazidime hydrolysis
24
ceftazidime
9
natural variants
8
variants kpc-2
8
increased catalytic
8
catalytic efficiency
8
efficiency ceftazidime
8
enzyme stability
8
penicillins cephalosporins
8
kpc-2 emerged
8

Similar Publications

Characterization of NWM-1, a novel subclass B3 metallo-β-lactamase found in a clinical isolate of Pseudomonas aeruginosa.

J Antimicrob Chemother

November 2024

German National Reference Centre for Multidrug-resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Universitätsstraße 150, 44801 Bochum, Germany.

Article Synopsis
  • The study aimed to understand how a clinical isolate of carbapenem-resistant Pseudomonas aeruginosa resists treatment by investigating its carbapenemase mechanism.
  • Researchers conducted various tests, including phenotypic tests and whole-genome sequencing, to detect and characterize a new metallo-β-lactamase (MBL) gene, named NWM-1, which had not been documented before.
  • The findings emphasize the importance of whole-genome sequencing in discovering new antibiotic resistance mechanisms, highlighting the ongoing evolution of resistance in clinical bacteria.
View Article and Find Full Text PDF

Objectives: In this study, we discovered bla in ceftazidime-avibactam resistant clinical isolates of K. pneumoniae from a patient with multiple comorbidities and investigated the resistance & transfer mechanism of bla.

Methods: K.

View Article and Find Full Text PDF

IMP-type metallo-β-lactamases are di-Zn(II) enzymes that can inactivate a wide range of bicyclic β-lactam agents used in clinical practice. IMP-27 shares 82% amino acid sequence identity with IMP-1, the first IMP-type enzyme identified. Herein, we conducted structural determination, kinetic, and chelating agent resistance analyses of IMP-27.

View Article and Find Full Text PDF

Introduction complex(BCC) is one of the most common polymyxin-resistant Gram-negative bacilli isolated in the clinical microbiological laboratory. They are often underreported when conventional biochemicals are used for identification, due to their similarity to other non-fermenting bacilli. It is essential to identify BCC using simple biochemical tests with good reliability to ease the identification of BCC in resource-limited settings and initiate treatment.

View Article and Find Full Text PDF
Article Synopsis
  • The overuse of β-lactam antibiotics has led to the development of resistance, particularly due to enzymes called β-lactamases, which hydrolyze these antibiotics.
  • Research focused on variants of the OXA-10 β-lactamase revealed three mutations (G157D, A124T, N73S) that significantly improved hydrolytic activity against ceftazidime, a broad-spectrum cephalosporin antibiotic.
  • The study shows how single amino acid changes can impact drug resistance and suggests that understanding these mutations can help improve existing drugs and aid in the creation of new β-lactam antibiotics.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!